Clinical Trials on Opiate Withdrawal Syndrome

Total 34433 results

University of Arkansas
National Institute on Drug Abuse (NIDA); Baylor College of Medicine

Completed

Carvedilol for Psychostimulant Dependence

Cocaine Dependence | Cocaine Withdrawal

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

Human Immunodeficiency Virus | Opiate Dependence

Russian Federation
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Evaluation of Bilateral HF-rTMS on Abstinence in Alcohol Use Disorder Patients With Executive Dysfunction (STIM-ALC)

Alcohol Withdrawal

France
PleoPharma, Inc.

Completed

Effect of PP-01 on Cannabis Withdrawal Syndrome

Cannabis Withdrawal

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Naltrexone for Pre-release Prisoners

Opiate Addiction

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Counseling for Primary Care Office-based Buprenorphine

Opiate Dependence

United States
University of Pennsylvania

Completed

Remote Observed Dosing to Increase Suboxone Compliance (RODISC)

Opiate Dependence

United States
Alkermes, Inc.

Completed

ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

Opiate Dependence

Russian Federation
Alkermes, Inc.

Completed

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Opiate Dependence
MacDonald, Kai, M.D.

Unknown

Oxytocin in Opiate Dependence: A Pilot Study of the Effects of Intranasal Oxytocin on Emotional Processes and Stress Responses in Patients With Opiate Dependence

Opiate Dependence

United States
State University of New York at Buffalo

Withdrawn

Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents

Opiate Addiction

United States
Hurd,Yasmin, Ph.D.

Completed

Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse

Opiate Addiction

United States
University of Oslo
The Research Council of Norway

Completed

Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services

Opiate Addiction

Norway
California Pacific Medical Center Research Institute

Completed

Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects (AIKO-150)

Opiate Addiction

United States
US Department of Veterans Affairs
National Institute on Drug Abuse (NIDA); Reckitt and Colman

Completed

Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice

Opiate Dependence

United States
Vilnius University

Completed

Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia

Opiate Dependence

Lithuania
University of Alabama at Birmingham

Withdrawn

Comparison of Three Opioid Detoxification Treatment Regimens

Opioid-Related Disorders | Opioid Withdrawal

United States
Mclean Hospital
VOX BIOMEDICAL LLC

Recruiting

Detecting Drugs of Abuse Via Exhaled Breath Samples Using Differential Mobility Spectrometry

Marijuana Abuse | Opiate Abuse

United States
Butler Hospital

Completed

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

Opioid Addiction

United States
Hurd,Yasmin, Ph.D.

Completed

Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans

Opiate Addiction

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1

Heroin Dependence

United States
University Hospital, Grenoble

Not yet recruiting

Brief Motivational Intervention (BMI) on the Deprescription of Benzodiazepines and Related Substances in Adult Chronic Drug Users (BENZ_HALTE)

Benzodiazepine Withdrawal

France
South West Sydney Local Health District
University of Sydney; South Eastern Sydney Local Health District

Unknown

Cannabidiol (CBD) for the Treatment of Alcohol Withdrawal

Alcohol Dependence | Alcohol Withdrawal

Australia
Virginia Polytechnic Institute and State University

Completed

Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II) (CAT)

Opiate Addiction

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Employment-Based Depot Naltrexone Clinical Trial II

Opiate Dependence

United States
Friends Research Institute, Inc.

Completed

Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment

Opiate Dependence

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Employment-Based Depot Naltrexone Clinical Trial

Opiate Dependence

United States
Ruijin Hospital
National Natural Science Foundation of China; Shanghai Mental Health Center; Suzhou... and other collaborators

Unknown

The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention

Opiate Addiction

China
Orexo AB
Worldwide Clinical Trials

Completed

Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence

Opioid-Related Disorders | Opiate Dependence

United States
Paolo Mannelli
Alkermes, Inc.

Completed

Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence (BUP/NXT-VIVI)

Opiate Dependence

United States
Kuopio University Hospital

Withdrawn

Compliance Monitoring in Real Time During Opioid Substitution Treatment

Opiate Dependence
The University of Texas Health Science Center,...
National Institute on Drug Abuse (NIDA)

Completed

Acceptance Therapy During Methadone Detoxification

Opiate Dependence

United States
China Medical University, Taiwan

Completed

The Clinical Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts

Opiate Dependence

Taiwan
Indivior Inc.
Taipei City Psychiatric Center, Taiwan

Completed

Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan

Opiate Dependence

Taiwan
Washington University School of Medicine

Recruiting

Continuous Versus Intermittent cARdiac Electrical moNitorinG (CARING)

Long QT Syndrome | Torsades de Pointe Caused by Drug

United States
Western University, Canada

Completed

The Acute Effects of Exercise and Caffeine on Working Memory During Acute Caffeine Deprivation

Caffeine Withdrawal | Acute Exercise | Memory Deficits

Canada
University of North Carolina, Chapel Hill

Completed

Oxytocin Treatment of Opioid Dependence

Opioid Dependence | Opioid Withdrawal

United States
TJ Biopharma Co., Ltd.

Recruiting

A Phase 3 Clinical Study to Evaluate Lemzoparlimab for Injection in Combination With Azacitidine (AZA) Versus AZA Monotherapy in Treatment-naïve Patients With Higher-risk Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes(MDS)

China
National Heart, Lung, and Blood Institute (NHLBI)
National Cancer Institute (NCI)

Recruiting

The National Myelodysplastic Syndromes (MDS) Study (MDS)

Myelodysplastic Syndromes (MDS)

United States, Israel
AbbVie
Celgene; Genentech, Inc.

Completed

A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes (MDS)

United States, Australia, Germany
AbbVie
Genentech, Inc.

Active, not recruiting

A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes (MDS)

United States, Australia, Canada, France, Germany, Italy, United Kingdom
The First Affiliated Hospital with Nanjing Medical...

Unknown

A Clinical Trial Evaluating the Efficacy of Ultra Low Dose of Decitabine in Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes (MDS)

China
SCRI Development Innovations, LLC
Novartis Pharmaceuticals

Terminated

LBH589 in Refractory Myelodysplastic Syndromes (MDS)

Myelodysplastic Syndromes (MDS)

United States
PersImmune, Inc
University of California, San Diego

Unknown

Collection of Samples From Patients With MDS

Myelodysplastic Syndromes(MDS)

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Impact of Lofexidine on Stress, Craving and Opioid Use

Opioid-use Disorder | Opiate Dependence

United States
Butler Hospital
National Institute on Drug Abuse (NIDA)

Completed

Insomnia and Drug Relapse Risk

Opiate Addiction | Poor Quality Sleep

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes

Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes

United States
National Cancer Institute (NCI)

Completed

Belinostat in Treating Patients With Myelodysplastic Syndromes

Previously Treated Myelodysplastic Syndromes | Secondary Myelodysplastic Syndromes | de Novo Myelodysplastic Syndromes

United States
Medical University of South Carolina

Completed

Gabapentin for Alcohol Relapse Prevention

Alcohol Use Disorder | Alcohol Withdrawal

United States
Steve N. Caritis, MD
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Terminated

Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy

Pregnancy | Opiate Addiction

United States

Clinical Trials on Opiate Withdrawal Syndrome

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations